Will President Biden Scrap GILTI? Congratulations to Brad Setser for being selected to be the Agency Review Team for the Office of the United States Trade Representative. I’m curious, however, as to his views on certain aspects of President Elect’s proposals with respect to corporate taxation. There were lots to criticize as to the 2017 Tax Cuts […]
(Dan here…this post has been lightly edited in format for readability) Trump’s Law & Order = Ronnie Thompson’s Shoot First and Ask Questions Later Summer Concepcion reports on something I find very alarming: President Trump leaned into his self-proclamation of being the President of “law and order” further as he appeared to approve of the “retribution” […]
Team Trump on Susan Rice as Biden’s Running Mate Next to Joe Biden, Susan Rice may be the most qualified person to lead our nation back from the utter disaster created by allowing Donald Trump to pretend to be our President. So what is this from the camp of the Liar-in-Chief? Trump’s aides and allies accuse Rice […]
A Republican Idea for Onshoring Pharmaceutical Intangible Assets Alex Parker reports on a proposal from Representative Darin LaHood: As part of the next round of pandemic relief, House Republicans are pushing new incentives for companies to bring home offshore intellectual property — something that they contend could boost job growth but that critics see as another […]
The 2017 Tax Cuts and Irish Jobs Act Brad Setser has more to say about how the lack of enforcement with respect to transfer pricing in the Big Pharma sector has not only cost us Federal tax revenues but perhaps in American jobs in his “The Irish Shock to U.S. Manufacturing?” (May 25, 2020): America’s production […]
Brad Setser on Offshoring Life Science Production and Transfer Pricing I just posted a discussion of an interesting proposal from Biden written by Alex Parker who mentioned some February 5, 2020 testimony from Brad Setser. The gist of this testimony was noted back in a March 26, 2019 blog post entitled When Tax Drives the Trade Data: […]
Biden Proposes Ending the GILTI Loophole Alex Parker covers an interesting and important tax policy issue: Former Vice President Joe Biden’s recent proposal to secure medical supply chains in the wake of the COVID-19 pandemic includes tweaks to the 2017 federal tax overhaul, reigniting the debate about whether its international provisions are pushing manufacturing facilities offshore […]
Favoring Hi-Tech Tax Cheats Over Consumers of French Wine Hoping to buy a nice bottle of French wine? Doug Palmer of Poltico has some bad news for you: The Trump administration announced Friday a 25 percent tariff on $1.3 billion worth of French handbags, cosmetics and soaps in retaliation for a digital services tax on U.S. internet […]
How Large is the Income Shifting Problem? I took up this invitation from Dan Shaviro: tomorrow morning I’ll be participating in a very interesting international tax policy conference with a number of outstanding participants. It’s on Zoom … I’m actually the second speaker on Panel II (although we’re listed above alphabetically), so I will be speaking from […]
Potential Pricing for Remdesivir The FDA has approved Remdesivir for emergency use and Gilead Science will denote its current 1.5 million vials, which could potentially treat 300 thousand patients as it takes 5 to 10 treatments per patient. The WHO wants more Remdesivir: The World Health Organization said Monday that it will speak with the U.S. government […]